Altered Nerve Myo-Inositol Metabolism in Experimental Diabetes and Its Relationship to Nerve Function

  • Douglas A. Greene
  • Sarah A. Lattimer
Part of the Experimental Biology and Medicine book series (EBAM, volume 6)


The following picture of altered myo-inositol metabolism in diabetic peripheral nerve has recently emerged. Hyperglycemia, through competitive inhibition of sodium-dependent myo-inositol uptake and/or increased polyol (sorbitol) pathway activity, reduces nerve myo-inositol content, secondarily altering nerve phosphoinositide metabolism and impairing the function of the membrane-bound sodium-potassium ATPase. The resulting reduction in the transmembrane sodium gradient impairs nerve conduction and further reduces sodium gradient-dependent myo-inositol uptake, creating a self-reinforcing metabolic defect in diabetic peripheral nerve. Other sodium-gradient dependent processes such as amino acid uptake and intracellular water and electrolyte homeostasis may also be secondarily altered. These abnormalities may have potentially widespread pathophysiological implications, possibly leading to the later structural defects in diabetic peripheral nerve, which are thought to underlie neurological deficits in diabetic neuropathy.


Diabetic Neuropathy Experimental Diabetes Aldose Reductase Inhibitor Motor Nerve Conduction Velocity Diabetic Nerve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brismar, T. and Sima, A.A.F. (1981) Acta Physiol. Scand. 113, 499–506.PubMedCrossRefGoogle Scholar
  2. Broekhuyse, R.M. (1968) Biochim. Biophys. Acta 163, 269–272.PubMedCrossRefGoogle Scholar
  3. Brown, M.J., Sumner, A.J., Greene, D.A., Diamond, S.M. and Asbury, A.K. (1980) Ann. Neurol. 8, 169–178.CrossRefGoogle Scholar
  4. Clements, R.S. (1979) Diabetes 28, 604–611.PubMedGoogle Scholar
  5. Clements, R.S. and Stockard, G.R. (1980) Diabetes 29,227–235.PubMedGoogle Scholar
  6. Das, P.K., Bray, G.M., Aguayo, A.J. and Rasminsky, M. (1976) Exp. Neurol. 53, 285–288.PubMedCrossRefGoogle Scholar
  7. Eliasson, S.G. (1964) J. Clin. Invest. 43, 2353–2358.PubMedCrossRefGoogle Scholar
  8. Eliasson, S.G. (1965) Lipids 1, 237–240.CrossRefGoogle Scholar
  9. Eliasson, S.G. (1969) J. Neurol. Neurosurg. Psychiat. 32, 525–529.PubMedCrossRefGoogle Scholar
  10. Fagius, J. and Jameson, S. (1981) J. Neurol., Neurosurg. Psychiat. 44, 991–1001.CrossRefGoogle Scholar
  11. Field, R.A. and Adams, L.C. (1964) Medicine 43, 275–279.PubMedGoogle Scholar
  12. Field, R.A. and Adams, L.C. (1965) Biochim. Biophys. Acta 106,474–479.PubMedGoogle Scholar
  13. Finegold, D., Lattimer, S.A., Nolle, S., Bernstein, M. and Greene, D.A. (1983) Diabetes 32, 988–992.PubMedCrossRefGoogle Scholar
  14. Gabbay, K.H. (1975) Ann. Rev. Med. 36, 521–536.CrossRefGoogle Scholar
  15. Gillon, K.R.W. and Hawthorne, J.N. (1983) Life Sciences 32, 1943–1947.PubMedCrossRefGoogle Scholar
  16. Greene, D.A. (1983) Metabolism 32 (Suppl. 1 ), 118–123.PubMedCrossRefGoogle Scholar
  17. Greene, D.A. and Lattimer, S.A. (1982) J. Clin. Invest. 70, 1009–1018.PubMedCrossRefGoogle Scholar
  18. Greene, D.A. and Lattimer, S.A. (1983) J. Clin. Invest. 72, 1058–1063.PubMedCrossRefGoogle Scholar
  19. Greene, D.A. and Lattimer, S.A. (1984a) Amer. J. Physiol. 246, E311–E318.Google Scholar
  20. Greene, D.A. and Lattimer, S.A. (1984b) Diabetes 33, 712–716.CrossRefGoogle Scholar
  21. Greene, D.A. and Winegrad, A.I. (1979) Diabetes 28, 878–887.PubMedCrossRefGoogle Scholar
  22. Greene, D.A. and Winegrad, A.I. (1981) Diabetes 30, 967–974.PubMedCrossRefGoogle Scholar
  23. Greene, D.A., DeJesus, P.V., Jr., and Winegrad, A.I. (1975) J. Clin. Invest. 55, 1326–1336.PubMedCrossRefGoogle Scholar
  24. Greene, D.A., Winegrad, A. I., Carpentier, J-L., Brown, M.J., Fukuma, M. and Orci, L. (1979) J. Neurochem. 33, 1007–1018.PubMedCrossRefGoogle Scholar
  25. Greene, D.A., Lewis, R.A., Lattimer, S.A. and Brown, M.J. (1982) Diabetes 31, 573–578.PubMedCrossRefGoogle Scholar
  26. Gregersen, G. (1968) Diabetologia 4, 273–277.PubMedCrossRefGoogle Scholar
  27. Hothersall, J.S. and McLean, P. (1979) Biochem. Biophys. Res. Comm. 88, 477–484.PubMedCrossRefGoogle Scholar
  28. Jakobsen, J. (1978) Diabetologia 14, 113–119.PubMedCrossRefGoogle Scholar
  29. Jakobsen, J. (1979) J. Neurol., Neurosurg., Psychiat. 42, 509–518.CrossRefGoogle Scholar
  30. Judzewitsch, R.G., Jaspan, J.B., Polonsky, K.S., Weinberg, C.R., Halter, J.B., Halar, E., Pfeifer, M.A., Vukaninovic, C., Bernstein, L., Schneider, M., Liang, K-Y., Gabbay, K.H., Rubenstein, A.H. and Porte, D., Jr. (1983) N. Engl. J. Med. 308, 119–125.PubMedCrossRefGoogle Scholar
  31. Kinoshita, J.H., Merola, L.O. and Dikmak, E. (1962a) Biochem. Biophys. Acta 62, 176–178.PubMedCrossRefGoogle Scholar
  32. Kinoshita, J.H., Merola, L.O. and Dikmak, E. (1962b) Eye Res. 1, 405–410.CrossRefGoogle Scholar
  33. Kuwabara, T., Kinoshita, J.H. and Cogan, D.G. (1969) Invest. Ophthalmol. 8, 133–149.PubMedGoogle Scholar
  34. Kyte, J. (1981) Nature 16, 201–204.CrossRefGoogle Scholar
  35. Lingham, R.B. and Sen, A.K. (1982) Biochim Biophys Acta 688, 475–485.PubMedCrossRefGoogle Scholar
  36. Mandersloot, J.G., Roelofsen, B. and De Gier, J. (1978) Biochim. Biophys Acta 508, 478–485.PubMedCrossRefGoogle Scholar
  37. Mayer, J.H. and Tomlinson, D.R. (1983) J. Physiol. 340, P25 - P26.Google Scholar
  38. Mayhew, J.A., Gillon, K.R.W. and Hawthorne, J.N. (1983) Diabetologia 24, 10–13.CrossRefGoogle Scholar
  39. Natarajan, V., Dyck, P.J. and Schmid, H.H.O. (1981) J. Neurochem. 36, 413–419.PubMedCrossRefGoogle Scholar
  40. Palmano, K.P., Whiting, P.H. and Hawthorne, J.N. (1977) Biochemical J. 167, 229–235.Google Scholar
  41. Ritchie, J.M. (1967) J. Physiol. 188, 309–329.PubMedGoogle Scholar
  42. Roelofsen, B. (1981) Life Sci. 29, 2235–2247.PubMedCrossRefGoogle Scholar
  43. Sharma, A.K. and Thomas P.K. (1974) J. Neurol. Sci. 23, 1–15.PubMedCrossRefGoogle Scholar
  44. Sima, A.A.F. (1980) Acta Neuropathol. 51, 223–227.PubMedCrossRefGoogle Scholar
  45. Simmons, D.A., Winegrad, A.I. and Martin, D.B. (1982) Science 217, 848–851.PubMedCrossRefGoogle Scholar
  46. Stewart, M.A., Sherman, W.R., Kurien, M.M., Moonsammy, G.I. and Wisgerhof, M. (1967) J. Neurochem. 14, 1057–1066.PubMedCrossRefGoogle Scholar
  47. Trachtenberg, M.C., Packey, D.J. and Sweeney, T. (1981) Current Topics in Cellular Regulation 19, 159–217.PubMedGoogle Scholar
  48. Unakar, N.J., Tsui, J.Y. and Harding, C.V. (1981) Ophthalmic Res. 13, 20–35.CrossRefGoogle Scholar
  49. Winegrad, A.I. and Greene, D.A. (1976) N. Engl. J. Med. 295, 1416–1421.PubMedCrossRefGoogle Scholar
  50. Winegrad, A.I., Clements, R.S., Jr. and Morrison, A.D. (1972) in: “Handbook of Physiology Sec 7 Vol I” (R.O. Greep, E.B. Astwood, D.F. Steiner, N. Freinkel and S.R. Geiger, eds.) pp. 457–471, Waverly Press, Baltimore.Google Scholar
  51. Yue, D.K., Hanwell, M.A., Satchell, F.M. and Turtle, J.R. (1982) Diabetes 31, 789–794.PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc. 1985

Authors and Affiliations

  • Douglas A. Greene
    • 1
  • Sarah A. Lattimer
    • 1
  1. 1.Diabetes Research Laboratories, Department of Medicine, School of MedicineUniversity of PittsburghPittsburghUSA

Personalised recommendations